[ Price : $8.95]
FDA releases the form FDA-483 with four observations from an inspection at the Dayton, NJ-based Hikma Injectables USA outsourcing ...[ Price : $8.95]
More than 260 reproductive health researchers urge FDA to continue to support mifepristone based on its 25-year record of safety a...[ Price : $8.95]
FDA says it has accepted an Echosens Letter of Intent to develop Liver Stiffness Measurement by Vibration-Controlled Transient Ela...[ Price : $8.95]
FDA accepts for review a Grace Therapeutics NDA for GTx-104 (nimodipine for injection) for treating patients with aneurysmal subar...[ Price : $8.95]
FDA approves supplemental BLAs from Moderna and Pfizer/BioNTech for their mRNA Covid-19 vaccines that target the LP.8.1 variant of...[ Price : $8.95]
Regeneron Pharmaceuticals releases favorable Phase 3 data for its RNA-based therapy cemdisiran and says it will seek FDA approval ...[ Price : $8.95]
Eli Lilly plans to seek approval for its investigational obesity pill orforglipron following positive topline results from the Pha...[ Price : $8.95]
FDA warns North Brunswick, NJ-based LeMaitre Vascular about Quality System Regulation and other violations in its manufacturing of...